Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 436 participants.

Also called NCT05686330

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 436 participants (enrolled count) (from the registry)
Sponsor
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) (from the registry)
Registry
  • NCT NCT05686330
Other papers using this trial's data
  • Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial Journal of the American College of Cardiology, 2026-04-14 DOI, PubMed 41569211

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05686330. Randomized; no masking; primary purpose diagnostic. Start 2022-11-16 (actual); primary completion 2025-07-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch)
Acronym
EQUAL
Intervention (Device)
Apple Watch
Lead sponsor
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) (class: other)

Record details

Record id
cardio:ct-nct05686330
Content hash
0e9f09b11473fcc9d5a60e1311867ed6873ac950d7f037c64a48a7f04b89c19c